Search Results

You are looking at 261 - 270 of 2,734 items for :

  • Refine by Access: All x
Clear All
Full access

Current Concepts in the Evaluation and Treatment of Patients With Diffuse Malignant Peritoneal Mesothelioma

Keli Turner, Sheelu Varghese, and H. Richard Alexander

that were independent factors associated with prolonged survival were age of 60 years or younger and complete or near-complete cytoreduction. The pathologic parameters associated with favorable outcome was absence of deep tissue invasion and a history

Full access

Counterpoint: The Case for Immediate Active Treatment

Stacy Loeb and William J. Catalona

of nonpalpable prostate cancer with curative intent: preliminary results . J Urol 2002 ; 167 : 1231 – 1234 . 8. Warlick C Trock BJ Landis P . Delayed versus immediate surgical intervention and prostate cancer outcome . J Natl Cancer

Full access

HSR20-076: Provider Versus Patient Reported Outcomes (PROs) in Colorectal Cancer (CRC) Patients (pts) Undergoing Systemic Therapy (Ctx): A Real World Experience

Sonali Agrawal, Caitlin R. Meeker, Sandeep Aggarwal, Elizabeth A. Handorf, Sunil Adige, Efrat Dotan, Crystal S. Denlinger, William H. Ward, Jeffrey M. Farma, and Namrata Vijayvergia

Full access

HSR22-163: Real World Data and Independent Predictors of Clinical Outcomes with CDK Inhibitors in Metastatic ER+ Breast Cancer Patients

Priyanka Reddy, James Martin, and Alberto Montero

Full access

NCCN Task Force Report: Optimizing Treatment of Advanced Renal Cell Carcinoma With Molecular Targeted Therapy

Gary R. Hudes, Michael A. Carducci, Toni K. Choueiri, Peg Esper, Eric Jonasch, Rashmi Kumar, Kim A. Margolin, M. Dror Michaelson, Robert J. Motzer, Roberto Pili, Susan Roethke, and Sandy Srinivas

carefully selected population than in patients enrolled in clinical trials. If not recognized and managed appropriately, these side effects may interfere with a patient's ability to continue on a treatment regimen, and may lead to poor outcomes or premature

Full access

Single-Arm Longitudinal Study to Evaluate a Decision Aid for Women Offered Neoadjuvant Systemic Therapy for Operable Breast Cancer

Nicholas Zdenkowski, Phyllis Butow, Andrew Spillane, Charles Douglas, Kylie Snook, Mark Jones, Christopher Oldmeadow, Sheryl Fewster, Corinna Beckmore, Frances M. Boyle, and for the Australia and New Zealand Breast Cancer Trials Group

different options. DAs have been shown to help guide patients in such preference-sensitive situations and improve decision-related outcomes, including reducing decisional conflict, increasing patient knowledge, increasing their involvement in decision

Full access

Validation of the Kattan Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy

Rochelle Payne Ondracek, Michael W. Kattan, Christine Murekeyisoni, Changhong Yu, Eric C. Kauffman, James R. Marshall, and James L. Mohler

diagnosis remains difficult. 2 – 5 Genetic and molecular markers for aggressive prostate cancer have improved, 6 , 7 but clinical nomograms continue to provide the most accurate tools to identify patients most likely to experience poor outcomes. 8 – 10

Full access

The Integration of Early Palliative Care With Oncology Care: The Time Has Come for a New Tradition

Jessica R. Bauman and Jennifer S. Temel

/print certificate. Release date: December 12, 2014; Expiration date: December 12, 2015 Learning Objectives Upon completion of this activity, participants will be able to: Describe the mechanisms through which early PC improves patient outcomes

Full access

Counterpoint: Robot-Assisted Laparoscopic Prostatectomy: Perhaps the Surgical Gold Standard for Prostate Cancer Care

Mark H. Kawachi

: 1738 – 1741 . 14. Menon M Shrivastava A Tewari A . Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes . J Urol 2002 ; 168 : 945 – 949 . 15. Wolfram

Full access

Healthcare Access Dimensions and Guideline-Concordant Ovarian Cancer Treatment: SEER-Medicare Analysis of the ORCHiD Study

Mary Katherine Montes de Oca, Lauren E. Wilson, Rebecca A. Previs, Anjali Gupta, Ashwini Joshi, Bin Huang, Maria Pisu, Margaret Liang, Kevin C. Ward, Maria J. Schymura, Andrew Berchuck, and Tomi F. Akinyemiju

improved survival outcomes, and lack of concordance with the NCCN Guidelines is an independent predictor of worse survival. 6 , 10 , 11 Some evidence suggests that equal care leads to similar outcomes among Black and White women with advanced OC 12 , 13